Page last updated: 2024-11-04

saccharin and Parkinson Disease

saccharin has been researched along with Parkinson Disease in 1 studies

Saccharin: Flavoring agent and non-nutritive sweetener.
saccharin : A 1,2-benzisothiazole having a keto-group at the 3-position and two oxo substituents at the 1-position. It is used as an artificial sweetening agent.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engeln, M1
Fasano, S1
Ahmed, SH1
Cador, M1
Baekelandt, V1
Bezard, E1
Fernagut, PO1

Other Studies

1 other study available for saccharin and Parkinson Disease

ArticleYear
Levodopa gains psychostimulant-like properties after nigral dopaminergic loss.
    Annals of neurology, 2013, Volume: 74, Issue:1

    Topics: Adenoviridae; alpha-Synuclein; Animals; Antiparkinson Agents; Conditioning, Operant; Disease Models,

2013